ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD). ENDRA's goal is to bring new capabilities to ultrasound - thereby broadening access to better healthcare. For more information, please visit www.endrainc.com. Non-Alcoholic Fatty Liver Disease (NAFLD) is a condition closely associated with obesity, diabetes, hepatitis-C and certain genetic predispositions in which fat accumulates in the liver. NAFLD affects over 1 billion people globally and is estimated to cost the U.S healthcare system over $100B annually. NAFLD is often asymptomatic and, If left untreated, NAFLD can progress to inflammation (NASH), tissue scarring (fibrosis), cell death (cirrhosis) and liver cancer. By 2025, NAFLD is forecast to be the greatest root cause of liver transplants. The only tools currently available for diagnosing and monitoring NAFLD are impractical: expensive Magnetic Resonance Imaging (MRI) or an invasive surgical biopsy.
View Top Employees from ENDRA Life Sciences (Nasdaq: NDRA)Website | http://www.endrainc.com |
Ticker | NDRA |
Revenue | $6 million |
Employees | 32 (24 on RocketReach) |
Founded | 2009 |
Address | 3600 Green Court Suite 350, Ann Arbor, Michigan 48105-1570, US |
Phone | (734) 335-0468 |
Technologies |
JavaScript,
HTML,
Twitter
+20 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Biotechnology, Diagnostic Equipment, Manufacturing, Science and Engineering, Monitoring Equipment, Health Care, Medical Device |
Web Rank | 5 Million |
Keywords | Endra, Endra Investor Relations, Endra Life Sciences, Ndra, Endra Life Science |
Competitors | Myocor, Neuspera Medical Inc., NovioSense BV, OncoSil Medical Limited, U-Systems , Inc. |
SIC | SIC Code 873 Companies, SIC Code 38 Companies, SIC Code 384 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular ENDRA Life Sciences (Nasdaq: NDRA) employee's phone or email?
The ENDRA Life Sciences (Nasdaq: NDRA) annual revenue was $6 million in 2024.
Scott Sober is the Senior Director of Operations of ENDRA Life Sciences (Nasdaq: NDRA).
24 people are employed at ENDRA Life Sciences (Nasdaq: NDRA).
ENDRA Life Sciences (Nasdaq: NDRA) is based in Ann Arbor, Michigan.
The NAICS codes for ENDRA Life Sciences (Nasdaq: NDRA) are [33, 334, 541, 54].
The SIC codes for ENDRA Life Sciences (Nasdaq: NDRA) are [873, 38, 384, 87].